cyclohexanol has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, C; Sun, J; Tang, F; Zhao, C | 1 |
| Kim, KY; Lee, HS; Seol, GH | 1 |
2 other study(ies) available for cyclohexanol and Lung Injury, Acute
| Article | Year |
|---|---|
1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Eucalyptol; Inflammation Mediators; Interleukin-10; Interleukin-1beta; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred ICR; Monoterpenes; Peroxidase; Pneumonia; Pulmonary Edema; Toll-Like Receptor 4; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Eucalyptol suppresses matrix metalloproteinase-9 expression through an extracellular signal-regulated kinase-dependent nuclear factor-kappa B pathway to exert anti-inflammatory effects in an acute lung inflammation model.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cyclohexanols; Cytokines; Dexamethasone; Disease Models, Animal; Drug Dosage Calculations; Eucalyptol; Extracellular Signal-Regulated MAP Kinases; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Monoterpenes; NF-kappa B; Nitric Oxide; Signal Transduction | 2015 |